Star Health and Allied Insurance  Gears Up for Q3 Reveal on 28th January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Star Health and Allied Insurance Q3 results for FY26 are scheduled to be announced on 28th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Star Health and Allied Insurance Q3 Results 2026 Preview

• Star Health and Allied Insurance revenue is expected to be in the range of ₹3,999.63 crore, a 2.23% YoY increase. 
• Profit After Tax, or PAT, is projected to rise by 90% YoY. 
• Star Health and Allied Insurance EBITDA is expected to rise to ₹149.00 crore. 
• Net profit is ₹215.14 crore, a rise 90% YoY 

Star Health and Allied Insurance Share Performance 

• Over the past six months, Star Health and Allied Insurance’s share price has risen by 0.52% to ₹425.80.
• Moreover, over the past year, the stock has increased by 4.29%.
• Despite this weak short-term performance, Star Health and Allied Insurance’s stock has delivered a financially sound 53.04% return over the past 5 years.
• As of 27th January 2026, the stock traded at ₹425.80 per share.

Key Factors to Watch for Star Health and Allied Insurance Q3 Results FY26 

• Gross Written Premium (GWP) growth – Trend in overall premiums, especially retail health premiums, as a key revenue driver.
• Profitability & underwriting performance – Net profit, combined ratio and claims ratio reflecting the balance between premium income and claims/expenses.
• Expense & cost ratios – Management expense ratio and impact of cost control initiatives on margins.
• Claims management & loss ratios – Trends in claims experience, medical inflation impact and solvency adequacy.
• Distribution & product mix – Growth in agency, bancassurance and digital channels along with product mix (e.g., retail vs group), shaping future earnings.

Final Thoughts

Star Health and Allied Insurance will announce its Q3 FY26 results on 28th January 2026. Analysts expect 4% YoY revenue growth, 90% rise in PAT, and a 30% rise in EBITDA. Star Health and Allied Insurance focuses on growing gross written premiums through diversified distribution while managing claims and expense ratios to sustain profitability.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Star Health and Allied Insurance elerator IPO GMP & Review: Apply or Avoid?

Vigor Plast India IPO Listing Preview: What to Expect Now?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates